Researchers will study antibiotic resistance in dogs with recurrent urinary tract infections caused by E. coli, as well as gut microbiota responses to antibiotics in dogs with and without multidrug-resistant e. coli strains, to help inform antibiotic use.
Researchers will evaluate the safety and efficacy of a novel combination of checkpoint inhibitor and adoptive T-cell therapy in giant-breed dogs diagnosed with appendicular osteosarcoma, a type of primary bone cancer of the limbs.
Using genotyping data from the Golden Retriever Lifetime Study, researchers will conduct a study to help identify genomic regions involved with increased susceptibility for hemangiosarcoma in American golden retrievers.
Researchers will study the health and well-being of service dogs paired with military veterans with post-traumatic stress disorders. They will use their findings to inform new tools to assess and track the well-being of these specially trained dogs.
Glaucoma is a leading and painful cause of blindness in dogs. Currently available interventions only delay blindness, highlighting the need for new and efficient therapies that preserve sight in affected...
Researchers are conducting a clinical trial to evaluate the ability of the drug trametinib to control tumor growth and improve outcomes for dogs with histiocytic sarcoma, an aggressive and usually fatal canine cancer.
Cancer researchers have been improving treatments for different cancers by identifying genetic variants (errors in the genetic code) in the tumors, and by identifying or developing new drugs that can...